Vistagen , a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called ...
Google's new Multi-Token Prediction drafters can make Gemma 4 run up to 3x faster on your own hardware—no cloud required, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results